top of page
Young scientist works in modern biologic

VitriLife Technology

The First Scalable Vitrification Platform for Biologics

VitriLife® is the first commercially scalable vitrification platform designed to stabilize sensitive biologics at industrial scale — without relying on freeze-drying. Our proprietary process enables shelf-stable, high-performance drug products that are easier to store, ship, and formulate.

Technology Highlights

  • A scalable alternative to lyophilization, offering enhanced stability and reproducibility

  • Immobilizes biologics in a foamed sugar-glass matrix to prevent molecular degradation

  • Preserves structure and activity by arresting rotational and translational motion

  • Extends shelf life and improves activity yields over time

  • Retains higher titer after drying and storage, minimizing potency loss

  • Reduces cold chain burden, cutting packaging and logistics costs

  • Supports micronization, enabling powder conversion without damaging the product

  • Compatible with combination products, including multi-component formulations

  • Reconstitutes instantly at the point of use — no lengthy prep or mixing

Screenshot 2025-05-15 at 8.56.01 PM.png

Formulation expertise across temperature-sensitive biologics

  • Vaccines

  • Monoclonal Antibodies

  • Hormones

  • Growth Factors

  • Therapeutic Proteins

  • Biosimilars

  • Live Biotherapeutic Products (LBPs)

Technology Comparison
Screen Shot 2021-09-23 at 4.36.15 PM.png
VitriLife® supports both bulk and vial-based production formats
Screen Shot 2021-09-23 at 4.35.26 PM.png
bottom of page